Unknown NA INTERVENTIONAL 2-arm NCT05645419

Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus

Development of Chronoprognosis of Myocardial Infarction in Patients With Type 2 Diabetes Mellitus and Development of Personalized Chronoprevention

Sponsor: University Medical Center, Kazakhstan

Conditions Clinical Study

Interventions personalized chronoprevention

Updated 4 times since 2023 Last updated: Dec 8, 2022 Started: Feb 28, 2023 Primary completion: Feb 28, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Clinical Study, this trial is ongoing. The trial is conducted by University Medical Center, Kazakhstan and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jan 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center, Kazakhstan

Data source: University Medical Center, Kazakhstan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Astana, Kazakhstan